Does Rallies show Form 4 insider transactions for USPH?

Yes. Rallies tracks USPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is USPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for USPH. It does not provide personalized investment advice.

USPH (US Physical Therapy Inc) Stock Analysis - Insider Trades

US Physical Therapy Inc (USPH) is a publicly traded Healthcare sector company. As of May 20, 2026, USPH trades at $62.16 with a market cap of $989.83M and a P/E ratio of 121.46. USPH moved +0.99% today. Year to date, USPH is -26.12%; over the trailing twelve months it is -21.61%. Its 52-week range spans $58.19 to $101.20. Analyst consensus is strong buy with an average price target of $97.50. Rallies surfaces USPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading USPH stock inside the company?

Recent USPH insider activity includes REEVE GRAHAM D. sold 662, REEVE GRAHAM D. sold 1, REEVE GRAHAM D. sold 1.81K, Binstein Richard sold 3.00K, and REEVE GRAHAM D. sold 743. Rallies tracks insider transaction dates, shares, prices, and estimated values.

USPH Key Metrics

Key financial metrics for USPH
Metric	Value
Price	$62.16
Market Cap	$989.83M
P/E Ratio	121.46
EPS	$0.51
Dividend Yield	0.46%
52-Week High	$101.20
52-Week Low	$58.19
Volume	184.99K
Avg Volume	0
Revenue (TTM)	$795.49M
Net Income	$52.69M
Gross Margin	19.03%

Recent USPH Insider Trades

REEVE GRAHAM D. sold 662 (~$52.21K) on Mar 11, 2026.
REEVE GRAHAM D. sold 1 (~$78.52) on Mar 9, 2026.
REEVE GRAHAM D. sold 1.81K (~$148.63K) on Mar 6, 2026.
Binstein Richard sold 3.00K (~$244.92K) on Mar 6, 2026.
REEVE GRAHAM D. sold 743 (~$52.76K) on Nov 24, 2025.

Latest USPH News

U.S. Physical Therapy Secures $450M Five-Year Credit Facility with Extended Maturity — Apr 15, 2026
U.S. Physical Therapy Faces 6% Cash Flow Margin Decline and 29x Forward P/E — Mar 5, 2026
US Physical Therapy Posts 16.3% Revenue Growth, Guides $102–106M EBITDA — Mar 1, 2026
US Physical Therapy Posts 16.3% Revenue Gain on 11.2% Visits Increase — Feb 26, 2026
U.S. Physical Therapy Sees Q4 Revenue Growth Slow to 10.5% — Feb 24, 2026

USPH Analyst Consensus

6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.50.

Common questions about USPH

Who is trading USPH stock inside the company?: Recent USPH insider activity includes REEVE GRAHAM D. sold 662, REEVE GRAHAM D. sold 1, REEVE GRAHAM D. sold 1.81K, Binstein Richard sold 3.00K, and REEVE GRAHAM D. sold 743. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for USPH?: Yes. Rallies tracks USPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is USPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for USPH. It does not provide personalized investment advice.